Cargando…

Figainin 1, a Novel Amphibian Skin Peptide with Antimicrobial and Antiproliferative Properties

Amphibian skin secretions are abundant in bioactive compounds, especially antimicrobial peptides. These molecules are generally cationic and rich in hydrophobic amino acids, have an amphipathic structure and adopt an α-helical conformation when in contact with microorganisms membranes. In this work,...

Descripción completa

Detalles Bibliográficos
Autores principales: Santana, Carlos José Correia, Magalhães, Ana Carolina Martins, dos Santos Júnior, Agenor C. M., Ricart, Carlos André Ornelas, Lima, Beatriz D., Álvares, Alice da Cunha Morales, de Freitas, Sonia Maria, Pires, Osmindo Rodrigues, Fontes, Wagner, Castro, Mariana S.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2020
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7559428/
https://www.ncbi.nlm.nih.gov/pubmed/32967114
http://dx.doi.org/10.3390/antibiotics9090625
Descripción
Sumario:Amphibian skin secretions are abundant in bioactive compounds, especially antimicrobial peptides. These molecules are generally cationic and rich in hydrophobic amino acids, have an amphipathic structure and adopt an α-helical conformation when in contact with microorganisms membranes. In this work, we purified and characterized Figainin 1, a novel antimicrobial and antiproliferative peptide from the cutaneous secretion of the frog Boana raniceps. Figainin 1 is a cationic peptide with eighteen amino acid residues—rich in leucine and isoleucine, with an amidated C-terminus—and adopts an α-helical conformation in the presence of trifluoroethanol (TFE). It displayed activity against Gram-negative and especially Gram-positive bacteria, with MIC values ranging from 2 to 16 µM, and showed an IC(50) value of 15.9 µM against epimastigote forms of T. cruzi; however, Figanin 1 did not show activity against Candida species. This peptide also showed cytolytic effects against human erythrocytes with an HC(50) of 10 µM, in addition to antiproliferative activity against cancer cells and murine fibroblasts, with IC(50) values ranging from 10.5 to 13.7 µM. Despite its adverse effects on noncancerous cells, Figainin 1 exhibits interesting properties for the development of new anticancer agents and anti-infective drugs against pathogenic microorganisms.